Update this profile
Latest Deal Type
Early Stage VC
Phagelux General Information Description
Developer of bacteriophages designed to provide alternatives to antibiotics for multiple fields. The company offers anti-bacterial products across multiple fields utilizing various phage and phage-based technologies, enabling users solve the bacterial problem and provide treatments to various diseases.
Want to dig into this profile?
We’ll help you find what you need
0.80%, 93rd %ile
219x, 100th %ile
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
00000000 000000000 14-Oct-2015
Iveria Technologies (Novel Delivery Systems)
To view Phagelux’s complete acquisitions history, request access »